Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07263802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 4, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The primary objective will be to evaluate the efficacy of GlycoDual in reducing fasting plasma glucose (FPG) and post-prandial plasma glucose (PPG) levels compared to placebo after 90 days of treatment. Secondary objectives are to estimate: * the change of insulin sensitivity (HOMA-IR) * the change of uricemia after 90 days of supplementation compared to placebo. Safety objectives: Collection of the adverse events not related, related or possibly related to the study products.
Trial Details
NCT Number NCT07263802
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions
(from sponsor)		 Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (Prediabetes)
Related terms Glucose Intolerance, Prediabetic State
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov